Tag - ips

 
 

IPS

Japan Times
BUSINESS
Apr 23, 2018
Putin's turf war with Telegram escalates as Russia blocks IPs
Russia's communications regulator blocked some Alphabet Inc. internet addresses, blaming the U.S. owner of Google for helping Pavel Durov's Telegram Messenger LLP service evade government blocking.
JAPAN / Science & Health
Jan 23, 2018
Unstable work seen as a factor as Kyoto University admits iPS researcher falsified data in paper
Experts say unstable employment conditions faced by scientists are behind the string of research-related scandals in the nation.
JAPAN / Science & Health
Nov 22, 2017
Japanese scientists find new drug combo that may be key to treating Alzheimer's
A team of Japanese researchers has found a new drug combination that reduces amyloid beta protein, believed to play a key role in causing Alzheimer's disease, by using stem cells derived from patients, Kyoto University announced Tuesday.
JAPAN / Science & Health
Aug 31, 2017
Kyoto University reprograms stem cells to fight Parkinson's in monkeys, a breakthrough for therapy
Japanese researchers successfully engineered cells to relieve Parkinson's symptoms in clinical trials, taking a step closer to a potential cure.
JAPAN / Science & Health
Aug 25, 2017
30% of Japanese may reject transplants of iPS cells derived from others: study
Some 30 percent of Japanese may experience rejection after receiving transplants of cells developed from induced pluripotent stem (iPS) cells derived from someone other than the patient, a Japanese research team has found.
JAPAN / Science & Health
Aug 7, 2017
World's first method for mass-producing platelets from iPS cells unveiled by Kyoto startup
A Kyoto startup unveils a way to mass-produce platelets, a key component in clotting, that could reduce doctors' dependency on donated blood to minimize bleeding.
Japan Times
JAPAN / Science & Health / A MATTER OF HEALTH
Jun 14, 2017
Transplants using iPS cells put Riken specialist at forefront of regenerative medicine research
When she entered medicine in the mid-1980s, Masayo Takahashi chose ophthalmology as her specialty, she said, because she wanted to have a family and thought the discipline would spare her from sudden work calls in the middle of the night, helping her best balance work and life.
Japan Times
BUSINESS / Companies
Jun 3, 2016
Fujifilm's new chief aims to make drug operations profitable
Fujifilm Holdings Corp.'s new president, Kenji Sukeno, aims to make its pharmaceutical operations profitable and said the company will consider acquisitions to bolster growth in sectors where it has an existing presence.
JAPAN / Science & Health
Feb 19, 2016
Japanese team finds new way to create, research Parkinson's stem cells
Researchers from Juntendo and Keio universities have come up with a quicker and easier way to generate iPS cells from people with Parkinson's disease, a discovery they claim will go a long way in developing a cure for the neurological disease.
BUSINESS / Companies / FOCUS
Jun 16, 2015
Nobel laureate Yamanaka allies with Takeda in hunt for blockbuster drugs
When Christophe Weber went after his first deal as head of Takeda Pharmaceutical Co., he veered off the well-worn path to the U.S. and Europe and went to Japan's Kyoto University instead.
BUSINESS / Companies
Mar 31, 2015
Fujifilm to acquire U.S. biotech company
Fujifilm Co. said Monday it will buy a U.S.-based developer of induced pluripotent stem (iPS) cells to strengthen its position in the field of regenerative medicine field, especially new drug development.
EDITORIALS
Mar 27, 2013
Making clinical use of iPS cells
Japan's Institute of Physical and Chemical Research asks the health ministry for permission to do a clinical study using iPS cells to treat eye disease.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji